| Titre : | PET/CT in multiple myeloma (2017) |
| Auteurs : | A. Nanni |
| Type de document : | Article |
| Dans : | Médecine nucléaire (vol. 41, n° 3, 2017) |
| Article en page(s) : | 216-220 |
| Langues: | Anglais |
| Descripteurs : |
HE Vinci Fluorodésoxyglucose F18 ; Imagerie par résonance magnétique ; Myélome multipleAutres descripteurs pet scan |
| Résumé : | Multiple myeloma is a plasma cell dyscrasia producing bone lytic lesions. In recent years, a wide spectrum of therapeutic approaches are available to treat the disease: an accurate therapy assessment has become, therefore, of utmost importance. In this field, imaging is becoming a cornerstone, especially in association to clinical parameters. Among imaging procedures, FDG PET/CT is recognized to provide reliable information, achieved in a very safe and fast procedure. Literature is producing very concordant results from different groups assessing the value of FDG PET/CT as a prognostic factor in general and in therapy assessment, but some issues remain regarding a standardization of image interpretation especially in borderline cases. So far, no data regarding nor other imaging compounds and the use of hybrid tomographs PET/MR are available to define therapy assessment in PET. |
| Disponible en ligne : | Oui/Non |
| En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.em-premium.com/revue/mednuc/41/3 |
Exemplaires (1)
| Cote | Support | Localisation | Section | Disponibilité |
|---|---|---|---|---|
| REV | Périodique papier | Woluwe | Espace revues | Consultation sur place uniquement Exclu du prêt |
